226 related articles for article (PubMed ID: 2774596)
1. Detection of hepatotoxicity associated with methotrexate therapy for psoriasis.
O'Connor GT; Olmstead EM; Zug K; Baughman RD; Beck JR; Dunn JL; Seal P; Lewandowski JF
Arch Dermatol; 1989 Sep; 125(9):1209-17. PubMed ID: 2774596
[TBL] [Abstract][Full Text] [Related]
2. Hepatotoxicity of long-term methotrexate therapy for psoriasis.
Tobias H; Auerbach R
Arch Intern Med; 1973 Sep; 132(3):391-6. PubMed ID: 4783020
[No Abstract] [Full Text] [Related]
3. Evaluation of possible chronic hepatotoxicity from methotrexate for psoriasis.
Weinstein GD; Cox JW; Suringa DW; Millard MM; Kalser M; Frost P
Arch Dermatol; 1970 Dec; 102(6):613-8. PubMed ID: 5501902
[No Abstract] [Full Text] [Related]
4. Hepatotoxicity of methotrexate in the treatment of psoriasis.
Palmer HM
Practitioner; 1973 Sep; 211(263):324-8. PubMed ID: 4759241
[No Abstract] [Full Text] [Related]
5. Hepatotoxicity of methotrexate in the treatment of psoriasis.
Roenigk HH; Bergfeld WF; St Jacques R; Owens FJ; Hawk WA
Arch Dermatol; 1971 Mar; 103(3):250-61. PubMed ID: 5548272
[No Abstract] [Full Text] [Related]
6. The use of transient elastography and FibroTest for monitoring hepatotoxicity in patients receiving methotrexate for psoriasis.
Lynch M; Higgins E; McCormick PA; Kirby B; Nolan N; Rogers S; Lally A; Vellinga A; Omar H; Collins P
JAMA Dermatol; 2014 Aug; 150(8):856-62. PubMed ID: 24964792
[TBL] [Abstract][Full Text] [Related]
7. Effects of methotrexate on the liver in psoriasis.
Reese LT; Grisham JW; Aach RD; Eisen AZ
J Invest Dermatol; 1974 Jun; 62(6):597-602. PubMed ID: 4835782
[No Abstract] [Full Text] [Related]
8. [Serum liver tests in patients treated with methotrexate. A retrospective analysis].
Correa G H; Paredes S N
Rev Med Chil; 2007 Aug; 135(8):1002-8. PubMed ID: 17989857
[TBL] [Abstract][Full Text] [Related]
9. Liver injury associated with methotrexate therapy for psoriasis.
Podurgiel BJ; McGill DB; Ludwig J; Taylor WF; Muller SA
Mayo Clin Proc; 1973 Nov; 48(11):787-92. PubMed ID: 4758150
[No Abstract] [Full Text] [Related]
10. Validity of noninvasive markers of methotrexate-induced hepatotoxicity: a retrospective cohort study.
Martyn-Simmons CL; Rosenberg WM; Cross R; Wong T; Smith CH; Barker JN
Br J Dermatol; 2014 Aug; 171(2):267-73. PubMed ID: 24942271
[TBL] [Abstract][Full Text] [Related]
11. [Incidence of liver diseases in psoriatic patients with special reference to methotrexate therapy].
Moldenhauer E; Dabels J; Diwok K; Leithäuser W; Nowotny P
Dermatol Monatsschr; 1973 Mar; 159(3):242-8. PubMed ID: 4704945
[No Abstract] [Full Text] [Related]
12. Liver disease in psoriatics--An effect of methotrexate therapy?
Shapiro HA; Trowbridge JO; Lee JC; Maibach HI
Arch Dermatol; 1974 Oct; 110(4):547-51. PubMed ID: 4414499
[No Abstract] [Full Text] [Related]
13. The value of dynamic hepatic scintigraphy and serum aminoterminal propeptide of type III procollagen for early detection of methotrexate-induced hepatic damage in psoriasis patients.
vanDooren-Greebe RJ; Kuijpers AL; Buijs WC; Kniest PH; Corstens FH; Nagengast FM; de Boo T; Willems JL; Duller P; van de Kerkhof PC
Br J Dermatol; 1996 Mar; 134(3):481-7. PubMed ID: 8731673
[TBL] [Abstract][Full Text] [Related]
14. Psoriasis-liver-methotrexate interactions.
Arch Dermatol; 1973 Jul; 108(1):36-42. PubMed ID: 4716740
[No Abstract] [Full Text] [Related]
15. The role of liver biopsies in psoriatic patients receiving long-term methotrexate treatment. Improvement in liver abnormalities after cessation of treatment.
Newman M; Auerbach R; Feiner H; Holzman RS; Shupack J; Migdal P; Culubret M; Camuto P; Tobias H
Arch Dermatol; 1989 Sep; 125(9):1218-24. PubMed ID: 2774597
[TBL] [Abstract][Full Text] [Related]
16. Dynamic hepatic scintigraphy in the screening of psoriatic patients for methotrexate-induced hepatotoxicity.
McHenry PM; Bingham EA; Callender ME; Delvin PB; O'Hara MD; Ferguson WR; Laird JD; Burrows D
Br J Dermatol; 1992 Aug; 127(2):122-5. PubMed ID: 1390139
[TBL] [Abstract][Full Text] [Related]
17. Liver biopsies in psoriatics--complications and evaluation.
Creswell SN; Burrows D
Int J Dermatol; 1980 May; 19(4):217-9. PubMed ID: 7399795
[TBL] [Abstract][Full Text] [Related]
18. Hepatic effects of long-term methotrexate use in the treatment of inflammatory bowel disease.
Te HS; Schiano TD; Kuan SF; Hanauer SB; Conjeevaram HS; Baker AL
Am J Gastroenterol; 2000 Nov; 95(11):3150-6. PubMed ID: 11095334
[TBL] [Abstract][Full Text] [Related]
19. Monitoring patients on methotrexate: hepatic fibrosis not seen in patients with normal serum assays of aminoterminal peptide of type III procollagen.
Maurice PD; Maddox AJ; Green CA; Tatnall F; Schofield JK; Stott DJ
Br J Dermatol; 2005 Mar; 152(3):451-8. PubMed ID: 15787813
[TBL] [Abstract][Full Text] [Related]
20. Galactose tolerance test and methotrexate-induced liver fibrosis and cirrhosis in patients with psoriasis.
Lenler-Petersen P; Søgård H; Thestrup-Pedersen K; Zachariae H
Acta Derm Venereol; 1982; 62(5):448-9. PubMed ID: 6183903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]